tiprankstipranks
Advertisement
Advertisement
Kazia Therapeutics Names Epigenetics Pioneer Sudha Rao as Chief Scientific Officer to Drive Oncology Platform
PremiumCompany AnnouncementsKazia Therapeutics Names Epigenetics Pioneer Sudha Rao as Chief Scientific Officer to Drive Oncology Platform
2M ago
Kazia Therapeutics appoints Sudha Rao as Chief Scientific Officer
Premium
The Fly
Kazia Therapeutics appoints Sudha Rao as Chief Scientific Officer
2M ago
Kazia Therapeutics initiated with a Buy at Laidlaw
Premium
The Fly
Kazia Therapeutics initiated with a Buy at Laidlaw
2M ago
Kazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance
PremiumCompany AnnouncementsKazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance
3M ago
Kazia Therapeutics’ NDL2 shows anti-tumor efficacy in preclinical data
Premium
The Fly
Kazia Therapeutics’ NDL2 shows anti-tumor efficacy in preclinical data
4M ago
Four new option listings and one option delisting on January 28th
Premium
The Fly
Four new option listings and one option delisting on January 28th
4M ago
Kazia Therapeutics regains Nasdaq compliance
PremiumThe FlyKazia Therapeutics regains Nasdaq compliance
6M ago
Kazia Therapeutics files to sell 10.7M American depositary shares for holders
Premium
The Fly
Kazia Therapeutics files to sell 10.7M American depositary shares for holders
6M ago
Kazia Therapeutics Retains Nasdaq Listing After Regaining Compliance
Premium
Company Announcements
Kazia Therapeutics Retains Nasdaq Listing After Regaining Compliance
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100